Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal...

Area of Science:

• Immunology
• Infectious Diseases
• Pharmacology

Background:

• Secondary bacterial pneumonia (SBP) following influenza significantly increases morbidity and mortality.
• Antibiotic-induced immunopathology from bacterial cell lysis may contribute to poor outcomes in SBP.
• Current antibiotic treatments are often insufficient for severe SBP.

Purpose of the Study:

• To investigate the efficacy of adjunctive dexamethasone therapy in a murine model of influenza-associated SBP.
• To evaluate the impact of dexamethasone timing on immune responses and disease severity in SBP.

Main Methods:

• Utilized a murine model of SBP following influenza infection.
• Stratified disease severity using in vivo bioluminescence imaging to quantify pneumococcal load.
• Administered ampicillin alone or in combination with dexamethasone at different time points.

Main Results:

• Ampicillin was effective in mild SBP but failed in severe SBP, despite bacterial killing.
• Adjunctive dexamethasone improved outcomes in severe SBP by mitigating ampicillin-induced immunopathology.
• Early dexamethasone during primary influenza infection increased viral titers and worsened SBP outcomes by impairing adaptive immunity.

Conclusions:

• Adjunctive corticosteroids may benefit patients with severe community-acquired pneumonia, particularly SBP.
• The timing of corticosteroid administration is critical to avoid detrimental effects on lung adaptive immunity.
• These findings support the clinical consideration of corticosteroids for severe SBP cases.